Home/Mironid/Dr Neil Wilkie
DN

Dr Neil Wilkie

Chief Executive Officer

Mironid

Therapeutic Areas

Mironid Pipeline

DrugIndicationPhase
PDE4 Allosteric Modulator ProgramAutosomal Dominant Polycystic Kidney Disease (ADPKD)Pre-clinical